tickdelta
Sign in
Screener / SEC EDGAR /CIK 0001932393 /10-K filed Feb 4, 2026, compared with Feb 13, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
BDXGEHCIQVUHSDHRBSX
Nasdaq Health care · Medical Imaging

GE HealthCare GEHC

GEHC quote by TradingView
Employees
54,000
Headquarters
Chicago, IL
CEO
Peter J. Arduini
Next results
around Feb 3, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $20.6B through the costs to a net profit of $2.1B · income statement of the 10-K

13% operating margin
Revenue to Gross profit: $8.2BRevenue to Cost of revenue: $12.4BGross profit to Operating profit: $2.8BGross profit to Operating expenses: $5.5BOperating profit to Net profit: $2.1BOperating profit to Tax & other: $679.0MOperating expenses to R&D: $1.3BOperating expenses to SG&A: $4.2B Revenue: $20.6B REVENUE $20.6B +5% Y/Y Gross profit: $8.2B · 40% margin GROSS PROFIT $8.2B 40% margin · +1% Y/Y Cost of revenue: $12.4B · 60% of revenue COST OF REVENUE $12.4B 60% of revenue Operating profit: $2.8B · 13% margin OPERATING PROFIT $2.8B 13% margin · +5% Y/Y Operating expenses: $5.5B · 27% of revenue OPERATING EXPENSES $5.5B 27% of revenue Net profit: $2.1B · 10% margin NET PROFIT $2.1B 10% margin · +5% Y/Y Tax & other: $679.0M · 3% of revenue TAX & OTHER $679.0M 3% of revenue R&D: $1.3B · 6% of revenue R&D $1.3B 6% of revenue SG&A: $4.2B · 20% of revenue SG&A $4.2B 20% of revenue
Gross profit $8.2B 40% margin · +1% Y/Y
Operating profit $2.8B 13% margin · +5% Y/Y
Net profit $2.1B 10% margin · +5% Y/Y
The full income statement, year by year

GEHC among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 59 peers the company is above, not a score.

Compare
Revenue growth: 4.8%, above 32% of 59 peers (their median 7.2%) REVENUE GROWTH 4.8% · above 32% Gross margin: 39.9%, above 24% of 50 peers (their median 65.2%) GROSS MARGIN 39.9% · above 24% Operating margin: 13.3%, above 48% of 50 peers (their median 13.7%) OPERATING MARGIN 13.3% · above 48% Net margin: 10.0%, above 53% of 59 peers (their median 9.5%) NET MARGIN 10.0% · above 53% FCF margin: 8.7%, above 27% of 55 peers (their median 15.8%) FCF MARGIN 8.7% · above 27% Return on capital: 10.0%, above 61% of 41 peers (their median 9.0%) RETURN ON CAPITAL 10.0% · above 61%
GEHC Peer median Below the median

What changed

9 new risk paragraphs and 2 accounting facts worth reading about. 10-K filed Feb 4, 2026 against Feb 13, 2025.

Risk factors
9 new paragraphs, nothing like them in the previous 10-K
10-K Item 1A
Cash from operations lower than net income
Cash from operations $2.0B vs net income $2.1B (FY ending Dec 31, 2025)
10-K · XBRL
Inventory growing faster than revenue
Inventory +15.2% vs revenue +4.8% (+10.4 pts)
10-K · XBRL
Accounting checks
8 other checks clear, 2 worth a look
10-K · XBRL
Insiders
No open-market buys in the last 90 days
Form 4
Filings
4 in the last 30 days
EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

10 checks on the latest 10-K. Checks, not verdicts.

How it works

2facts worth reading about the other 8 checks found nothing to note

  • Cash from operations lower than net income
    Cash from operations $2.0B vs net income $2.1B (FY ending Dec 31, 2025)
  • Inventory growing faster than revenue
    Inventory +15.2% vs revenue +4.8% (+10.4 pts)
  • Same auditor in both 10-Ks: Deloitte & Touche LLP
7 more checks with nothing to note
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • No longer listed: Income Taxes - Valuation Allowance on Deferred Tax Assets
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

9 paragraphs in Risk Factors that were not in the 10-K filed Feb 13, 2025. Quoted as filed.

All 9 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 13, 2025 10-K, ITEM 1A
    This summary of risks is intended to provide an overview of the principal risks we face and should not be considered a substitute for a review of the more detailed risk factors discussed immediately following this summary. •Our business is subject to the effects of global geopolitical and economic instability and public health crises.

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$18.3B$19.6B$19.7B$20.6B
Net income$1.9B$1.6B$2.0B$2.1B
Operating cash flow$2.1B$2.1B$2.0B$2.0B
Free cash flow$1.8B$1.7B$1.6B$1.5B

Revenue, FY2021 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$20.6B ▲ 4.8% in FY2025

FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

4 filings in the last 30 days · SEC EDGAR

All filings

About the company

GE HealthCare, Chicago, IL · from the 10-K filed Feb 4, 2026

GE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “our,” “us,” or “we”) is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. We have approximately 54,000 colleagues dedicated to our purpose to create a world where healthcare has no limits. Serving patients and providers for nearly 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalized, precise patient care.

Headquarters
Chicago, IL
Country
United States
Reports in
USD
Listed on
Nasdaq
Fiscal year ends
December 31
Last results
Oct 28, 2026
Incorporated in
DE

Employees, at the top of the page: "We have approximately 54,000 colleagues dedicated to our purpose to create a world where healthcare has no limits" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Feb 4, 2026 (open at SEC), compared with the 10-K filed Feb 13, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/GEHC/export.csv") into a cell.